Recently, blockade of VEGFR-3 signaling by soluble VEGFR-3 (sVEGFR-3) or the blocking antibody inhibits lymph node metastasis in experimental animal cancer models and associated with reduction in lymphangiogenesis but not anginogenesis of the tumors [2-6]. This evidence concerns the gene FLT4 and cancer.